Danazol loaded intrauterine device (D-IUD): A novel conservative management for uterine adenomyosis

Middle East Fertility Society Journal

Volumn 7, Issue 3, 2002, Pages 214-220

  Shawki, Osama A ^a,b  

^a CAIRO UNIVERSITY   (Egypt)

^b Al Ebtesama Hopsital   (Egypt)

Author keywords

Adenomyosis; Danazol; Drug delivery system; Dysmenorrhea; Intrauterine device; Menorrhagia

Indexed keywords

DANAZOL;

ACNE; ADENOMYOSIS; ADULT; ARTICLE; BODY WEIGHT DISORDER; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; FEMALE; FEMALE INFERTILITY; HEMOGLOBIN DETERMINATION; HUMAN; HYSTEROSCOPY; INTRAUTERINE CONTRACEPTIVE DEVICE; LIVER DYSFUNCTION; MENSTRUATION; PARTHENOGENESIS; PELVIS PAIN SYNDROME; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; UTERUS BIOPSY; VISUAL ANALOG SCALE;

EID: 0036972575     PISSN: 11105690     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Azziz R. Adenomyosis: current perspectives. Obstet Gynecol Clin North Am 1989; 16: 221-35.
2. Arnold LL, Ascher SM, Scruefer JJ, Simon JA. The nonsurgical diagnosis of adenomyosis. Obstet Gynecol 1995; 86: 461-5.
3. Bazot M, Cortez A, Darai E, rouger J, Chopier J, Antoine JM, Uzan S. Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histology. Hum Reprod 2001; 16(11): 2427-33
4. Dueholm M, Lundorf E, Hansen ES, Sorensen JS, Ledertoug S, Olesen F. Magnetic resonance imaging and Transvaginal ultrasonography for the diagnosis of adenomyosis. Fertil Steril 2001 Sep; 76(3): 588-94
5. Morgante G, Ditto A, La Marca A, De Leo V. Low dose danazol for combined surgical and medical therapy reduces the incidence of pelvic pain in women with moderate to severe endometriosis. Hum Reprod 1999; 14(9): 2371-4
6. Selak V, Farquhar C, Prentice A, Singla A. Danazol for pelvic pain associated endometriosis. Cochrane Database Syst Rev 2001; (4) CD000086. Review
7. Spooner JB. Classification of side-effects to Danazol therapy. J Int Med Res 1977; 5: 15-7.
8. Wynn V. Metabolic effects of danazol. J Int Med Res 1977; 5: 25-35.
9. Braun DP, Gebel H, and Dmowski WP. Effect of Danazol in vitro and in vivo on monocyte-mediated enhancement of endometrial cell proliferation in women with endometriosis. Fertil Steril 1994; 62: 89-95.
10. Chin K, Tanaka T, Mizuno K, et al. (1997): In vitro augmentative effect of danazol on apoptosis of endometrial cells. Abstract of 18th Annual Meeting of Japan Endometriosis Association, p 13.
11. Kokko E, Janne O, Kauppila A, Ronnberg L, Vihko R Danazol has progestin-like actions on the human endometrium. Acta Endocrinol (Copenh) 1982 Apr; 99(4): 588-93
12. Igarashi M. A new therapy for pelvic endometriosis and uterine adenomyosis: Local effect of vaginal and intrauterine Danazol application. Asia-Oceania J Obstet Gynaecol 1990; 16: 1-12.
13. Igarashi Yumiko Abe, Masaki Fukuda, Akihiko Ando, Makihiro Miyasaka and Mitunori Yoshida (2000). Fertil Steril Vol. 74, No 2, August 2000, 412-413
14. Fedele L, Bianchi S, Dorrta M, et al. Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis. Fertil Steril 1992; 58: 94-97
15. Mc Causland AM. Hysteroscopic endomyometrial biopsy: Its use in diagnosing adenomyosis and its clinical application. Am J Obstet Gynecol 1992; 166: 1619-1628.
16. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br. J Obstet Gynecol 1990; 97: 734-9
17. Bayer SR, Seibel MM, Saffan DS, Berger MJ, Taymor ML Efficacy of danazol treatment for minimal endometriosis in infertile women. A prospective, randomized study. J Reprod Med 1988 Feb; 33(2): 179-83
18. Wood C, Maher P, Hill D. Biopsy diagnosis and conservative surgical treatment of adenomyosis. Aust New Zealand J Obstet Gynecol 1993; 33: 319-321.
19. Vercellini P, Aimi G, Panazza S, De Giorgi O, Pesole A, Crosignani PG. A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil Steril 1999; 72(3): 505-8
20. Hidalgo M, Bahamondes L, Perrotti M, Diaz J, Dantas-Monteiro C, Petta C. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 2002; 65(2): 129-32
21. Vercellini P, Aimi G, Panazza S, De Giorgi O, Pesole A, Crosignani PG. A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil Steril 1999; 72(3): 505-8
22. Fedele L, Bianchi S, Raffaelli R, Portuese A, Dorta M. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril 1997; 68(3): 426-9
23. Chamness GC, Asch RH, and Pauerstein CJ. Danazol binding and translocation of steroid receptors. Am J Obstet Gynecol 1980; 136: 426-429.
24. Taketani Y, and Mizuno M. Direct action of Danazol on endometrial cells in vitro. Sanka To Jujinka 1985;(in Japanese) 8: 89-91.
25. Surrey ES and Halme J. Direct effects of medroxyprogesterone acetate, danazol, and leuprolide acetate on endometrial stromal cell proliferation in vitro. Fertil Steril 1992; 58: 273-278.
26. Igarashi M, Lizuka M, Abe Y, et al. (1996): A new therapy for deeply-infiltrating endometriosis and uterine adenomyosis: Topical Danazol therapy. Abstract of Vth World Congress on Endometriosis, Yokohama, Japan. p. 80.
27. Igarashi M, Lizuka M, Abe Y, et al. A novel therapy for deeply-infiltrating endometriosis and uterine adenomyosis: Topical danazol therapy. Acta Obstet. Et Gynecol. Scand. 1997 Supplement 76, No. 167-3, p 30. Abstract of XV FIGO World Congress of Gynecol. and Obstet. Copenhagen.
28. Tamaoka, Y., Sho, R., Yamamoto, Y., et al., (1996): Investigation of treatment of adenomyosis by intrauterine device that contains danazol. Abstracts of Vth World Congress on Endometriosis, Yokohama, Japan, 80 pp.
29. Tamaoka Y, Osawa Y, Sumi Y, et al. New method of treatment of adenomyosis with intrauterine device containing danazol. Acta Obstet Gynecol Scand 1997 Supplement. 76, No. 167-4, 67 pp. Abstract of XV FIGO World Congress of Gynecol. and Obstet., Copenhagen.
30. Mizutani T, Nishiyama S, Amakawa I, Watanabe A, Nakamuro K, Terada N. Danazol concentrations in ovary, uterus, and serum and their effect on the hypothalamic-pituitary-ovarian axis during vaginal administration of a danazol suppository. Fertil Steril 1995 Jun; 63(6): 1184-9